These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21311500)

  • 1. Pilot trial of late booster doses of surfactant for ventilated premature infants.
    Merrill JD; Ballard PL; Courtney SE; Durand DJ; Hamvas A; Hibbs AM; Lu KW; Ryan RM; Reynolds AM; Spence K; Steinhorn RH; Truog WE; Eichenwald EC; Ballard RA
    J Perinatol; 2011 Sep; 31(9):599-606. PubMed ID: 21311500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study.
    Keller RL; Merrill JD; Black DM; Steinhorn RH; Eichenwald EC; Durand DJ; Ryan RM; Truog WE; Courtney SE; Ballard PL; Ballard RA
    Pediatr Res; 2012 Dec; 72(6):613-9. PubMed ID: 23037875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide.
    Ballard RA; Keller RL; Black DM; Ballard PL; Merrill JD; Eichenwald EC; Truog WE; Mammel MC; Steinhorn RH; Rogers EE; Ryan RM; Durand DJ; Asselin JM; Bendel CM; Bendel-Stenzel EM; Courtney SE; Dhanireddy R; Hudak ML; Koch FR; Mayock DE; McKay VJ; O'Shea TM; Porta NF; Wadhawan R; Palermo L;
    J Pediatr; 2016 Jan; 168():23-29.e4. PubMed ID: 26500107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant status and respiratory outcome in premature infants receiving late surfactant treatment.
    Ballard PL; Keller RL; Truog WE; Chapin C; Horneman H; Segal MR; Ballard RA;
    Pediatr Res; 2019 Feb; 85(3):305-311. PubMed ID: 30140069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
    Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
    J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
    Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
    Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunction of pulmonary surfactant in chronically ventilated premature infants.
    Merrill JD; Ballard RA; Cnaan A; Hibbs AM; Godinez RI; Godinez MH; Truog WE; Ballard PL
    Pediatr Res; 2004 Dec; 56(6):918-26. PubMed ID: 15496605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
    Corbet A; Gerdes J; Long W; Avila E; Puri A; Rosenberg A; Edwards K; Cook L
    J Pediatr; 1995 Jun; 126(6):969-78. PubMed ID: 7776110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome.
    Garland JS; Buck RK; Allred EN; Leviton A
    Arch Pediatr Adolesc Med; 1995 Jun; 149(6):617-22. PubMed ID: 7767415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
    Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
    Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia.
    Cogo PE; Zimmermann LJ; Pesavento R; Sacchetto E; Burighel A; Rosso F; Badon T; Verlato G; Carnielli VP
    Crit Care Med; 2003 May; 31(5):1532-8. PubMed ID: 12771629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
    Laughon M; Bose C; Moya F; Aschner J; Donn SM; Morabito C; Cummings JJ; Segal R; Guardia C; Liu G;
    Pediatrics; 2009 Jan; 123(1):89-96. PubMed ID: 19117865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of surfactant administration through a thin catheter in the delivery room: A quality control chart analysis coupled with a propensity score matched cohort study in preterm infants.
    Berneau P; Nguyen Phuc Thu T; Pladys P; Beuchée A
    PLoS One; 2018; 13(12):e0208252. PubMed ID: 30540816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial.
    Gortner L; Bartmann P; Pohlandt F; Bernsau U; Porz F; Hellwege HH; Seitz RC; Hieronimi G; Bremer C; Jorch G
    Pediatr Pulmonol; 1992 Sep; 14(1):4-9. PubMed ID: 1437342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop bronchopulmonary dysplasia.
    Kazzi SN; Schürch S; McLaughlin KL; Romero R; Janisse J
    Acta Paediatr; 2000 Oct; 89(10):1218-25. PubMed ID: 11083379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.